Sensitivity, specificity, accuracy, percentage and error percentage of prostatic specific antigen [PSA] in diagnosis of cancer prostate
El-Minia Medical Bulletin. 1996; 7 (2): 1-6
in English
| IMEMR
| ID: emr-40983
ABSTRACT
Prostatic Specific Antigen [PSA] have been estimated in 20 normal males above fifty [control group] and 22 patients with cancer prostate [cases]. Detection of antigen by immunoassay method and diagnosis was confirmed by histopathology, sensitivity, and specificity Accuracy percentage and error percentage of PSA in diagnosis of cancer prostate in patients with metastasis were [95.2 percent, 100 percent, 95.5 percent and 4.5 percent respectively] and in patients without metastasis [85.7 percent, 100 percent, 86.4 percent and 13.6 respectively]. PSA detection is recommended for early detection and screening of any suspected prostatic swelling
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Biomarkers, Tumor
/
Prostate-Specific Antigen
Type of study:
Screening study
Limits:
Humans
/
Male
Language:
English
Journal:
El-Minia Med. Bull.
Year:
1996
Similar
MEDLINE
...
LILACS
LIS